drugset

drugset / Trial / NCT01485328

Protocol: Phytomedicine-AMARGOL®, Clinical Trial for Efficacy Proof on Therapeutics

NCT01485328 ↗

Phase 3 Completed 60 enrolled Laboratorio Saude Ltda. Phytopharm Consulting Brazil · collab

RandomizedParallel-groupTriple-blindTreatment

Summary

This is a Phase 3: Efficacy Study for AMARGOL® a phytomedicine used for asymptomatic digestive complaints.

Timeline

Start: 2008-12
Primary completion: 2009-04
Completion: 2009-09

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	AMARGOL®	Unknown	40 ml	Oral

Indications